These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

993 related items for PubMed ID: 26748470

  • 1. Patients with large-duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without IBD.
    Fevery J, Van Steenbergen W, Van Pelt J, Laleman W, Hoffman I, Geboes K, Vermeire S, Nevens F.
    Aliment Pharmacol Ther; 2016 Mar; 43(5):612-20. PubMed ID: 26748470
    [Abstract] [Full Text] [Related]

  • 2. Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.
    Weismüller TJ, Trivedi PJ, Bergquist A, Imam M, Lenzen H, Ponsioen CY, Holm K, Gotthardt D, Färkkilä MA, Marschall HU, Thorburn D, Weersma RK, Fevery J, Mueller T, Chazouillères O, Schulze K, Lazaridis KN, Almer S, Pereira SP, Levy C, Mason A, Naess S, Bowlus CL, Floreani A, Halilbasic E, Yimam KK, Milkiewicz P, Beuers U, Huynh DK, Pares A, Manser CN, Dalekos GN, Eksteen B, Invernizzi P, Berg CP, Kirchner GI, Sarrazin C, Zimmer V, Fabris L, Braun F, Marzioni M, Juran BD, Said K, Rupp C, Jokelainen K, Benito de Valle M, Saffioti F, Cheung A, Trauner M, Schramm C, Chapman RW, Karlsen TH, Schrumpf E, Strassburg CP, Manns MP, Lindor KD, Hirschfield GM, Hansen BE, Boberg KM, International PSC Study Group.
    Gastroenterology; 2017 Jun; 152(8):1975-1984.e8. PubMed ID: 28274849
    [Abstract] [Full Text] [Related]

  • 3. Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: prevalence, risk factors, and long-term follow-up.
    Fraga M, Fournier N, Safroneeva E, Pittet V, Godat S, Straumann A, Nydegger A, Vavricka SR, Moradpour D, Schoepfer AM, Swiss IBD Cohort Study Group.
    Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):91-97. PubMed ID: 27622999
    [Abstract] [Full Text] [Related]

  • 4. Inflammatory bowel disease with primary sclerosing cholangitis: A Danish population-based cohort study 1977-2011.
    Sørensen JØ, Nielsen OH, Andersson M, Ainsworth MA, Ytting H, Bélard E, Jess T.
    Liver Int; 2018 Mar; 38(3):532-541. PubMed ID: 28796371
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of inflammatory bowel disease among patients with primary sclerosing cholangitis in Iran.
    Hadizadeh M, Abedi SH, Malekpour H, Radinnia E, Jabbehdari S, Padashi M, Zali MR, Mohammad Alizadeh AH.
    Arab J Gastroenterol; 2016 Mar; 17(1):17-9. PubMed ID: 27032493
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [CLINICAL AND MORPHOLOGICAL CHARACTERISTICS OF INTESTINAL LESIONS IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS].
    Pazenco EV, Karev VE, Raikhelson KL, Shchukina OB, Botina AV, Kharitonov AG, Semenov NV.
    Eksp Klin Gastroenterol; 2016 Mar; (7):18-24. PubMed ID: 30284417
    [Abstract] [Full Text] [Related]

  • 10. Hepatobiliary dysfunction and primary sclerosing cholangitis in patients with Crohn's disease.
    Rasmussen HH, Fallingborg JF, Mortensen PB, Vyberg M, Tage-Jensen U, Rasmussen SN.
    Scand J Gastroenterol; 1997 Jun; 32(6):604-10. PubMed ID: 9200295
    [Abstract] [Full Text] [Related]

  • 11. Outcome of Very Early Onset Inflammatory Bowel Disease Associated With Primary Sclerosing Cholangitis: A Multicenter Study From the Pediatric IBD Porto Group of ESPGHAN.
    Catassi G, D'Arcangelo G, Norsa L, Bramuzzo M, Hojsak I, Kolho KL, Romano C, Gasparetto M, Di Giorgio A, Hussey S, Yerushalmy-Feler A, Turner D, Matar M, Weiss B, Karoliny A, Alvisi P, Tzivinikos C, Aloi M.
    Inflamm Bowel Dis; 2024 Oct 03; 30(10):1662-1669. PubMed ID: 37768032
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical aspects and prognosis of patients with inflammatory bowel disease associated with autoimmune liver diseases.
    Rocha HC, Vilela EG.
    Gastroenterol Hepatol; 2022 Feb 03; 45(2):83-90. PubMed ID: 34023469
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients?
    Bayraktar Y, Arslan S, Saglam F, Uzunalimoglu B, Kayhan B.
    Hepatogastroenterology; 1998 Feb 03; 45(24):2064-72. PubMed ID: 9951867
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Barberio B, Massimi D, Cazzagon N, Zingone F, Ford AC, Savarino EV.
    Gastroenterology; 2021 Dec 03; 161(6):1865-1877. PubMed ID: 34425093
    [Abstract] [Full Text] [Related]

  • 17. Primary sclerosing cholangitis associated with inflammatory bowel disease: an update.
    Rossi RE, Conte D, Massironi S.
    Eur J Gastroenterol Hepatol; 2016 Feb 03; 28(2):123-31. PubMed ID: 26636407
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease.
    Boonstra K, van Erpecum KJ, van Nieuwkerk KM, Drenth JP, Poen AC, Witteman BJ, Tuynman HA, Beuers U, Ponsioen CY.
    Inflamm Bowel Dis; 2012 Dec 03; 18(12):2270-6. PubMed ID: 22407885
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.